Data shows that the two-dose measles vaccine is 97% effective at preventing measles and experts say protection doesn’t wane.

Kennedy Jr., secretary of health ... misinformation and stressed that the vaccine is safe and effective Kennedy is now asking the CDC to develop new guidance for treating measles with medications ...

Speaking with NewsNation, virulent vaccine conspiracist and Department of Health and Human Services Secretary Robert F. Kennedy Jr. justified ... views on the political issues of the day ...

Kennedy Jr. has minimized the risk COVID-19 poses to kids and exaggerated the risk of the vaccine, incorrectly ... and “we have not received any guidance requiring the removal of content ...

U.S. Rep. Mark Pocan (D-Wis.) asked Kennedy during a House Appropriations Committee hearing on Wednesday whether he would choose to vaccinate his children against measles. Kennedy, a longtime vaccine skeptic, dodged the question, then stated that Americans should not be taking “medical advice” from him.

She has covered the persecution of religions in the global south, fertility and birth rate issues ... vaccine," the Children's Hospital of Philadelphia says in its Q&A sheet on the topic. RFK Jr ...

Kennedy Jr. misleadingly claimed that Europe doesn ... Kennedy, a longtime anti-vaccine advocate, refused to definitively say when asked by Rep. Mark Pocan, a Democrat of Wisconsin, whether ...

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct major new clinical trials before approving them for wider use.

Kennedy Jr. intends to shift the ... Kennedy has previously claimed that vaccine testing studies are not long enough to capture potential safety issues, although vaccines are continuously and ...

The FDA will encourage new clinical trials on the widely used vaccines before approving them for children and healthy adults. The requirements could cost drugmakers tens of millions of dollars and are likely to leave boosters largely out of reach for hundreds of millions of Americans this fall.